Cmed shows encapsia® at 2017 ASCO Annual Meeting

Written by Cmed

Cmed, an innovative technology-led oncology CRO, today announced it will be exhibiting at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois (June 3-5), and showing how encapsia can help improve patient safety, study conduct and decision making in oncology clinical trials (Booth 23128).

Cmed has earned a strong reputation for successfully conducting oncology trials across all phases and in numerous cancer types, including breast, lung, prostate, colorectal and other solid cancers, and haematological malignancies. This experience now coupled with encapsia, a proven new generation clinical data suite already used by some big and small Biopharma Sponsors, enables Cmed to provide its Sponsors with previously unheard of ability to collect, review, decide and take actions on their clinical trial data.

Visitors are invited to join Cmed at booth 23128 to see live demonstrations of the benefits encapsia brings to oncology trials and learn more about how other Sponsors are benefiting.

To schedule a meeting with the Cmed team during ASCO 2017, contact Patrick Maloney, Director of Business Development at, or Jessi Lanuza, Associate Director of Business Development at